TIMP1 has been demonstrated to be involved in the progression of tumors involving lung adenocarcinoma, glioma, prostate cancer, breast cancer, colorectal cancer and a number of other cancers [15]. This evidence concerns the gene TIMP1 and breast carcinoma.